Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2020

Jun 18, 2020

33003_dirs_2020-06-18_ecfce816-7162-48c9-8c77-0d1136234d79.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-06-16

Reporting Person: SMITH IAN F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-16 Director Stock Option (Right to Buy) $3.03 A 200000 Acquired 2030-06-16 Common Stock (200000) Direct

Footnotes

F1: This option was granted on June 16, 2020 and will vest in equal quarterly installments beginning three months from the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.